BD Pharmingen- APC Rat Anti-Mouse IL-10_BD Pharmingen
参考图片
Expression of IL-10 by stimulated CD4+ Balb/c spleen cells. Purified splenic CD4+ cells from 6 month old BALB/c mice were stimulated with plate-bound anti-CD3 (145-2C11, Cat. No. 553057 at 25 µg/ml) and soluble anti-mouse CD28 (clone 37.51, Cat. No. 553296 at 2 µg/ml) for 2 days in culture together with recombinant mouseIL-2 (10 ng/ml, Cat. No. 550069) and recombinant mouse IL-4 (50 ng/ml, Cat. No. 550067), followed by a 3 day incubation with only IL-2 and IL-4. This was followed by a 5 hour stimulation with plate-bound anti-CD3 (25 µg/ml) and anti-mouse CD28 (2 µg/ml) in the presence of GolgiStop™ (Cat. No. 554724). The cells were then stained with 0.06 µg of FITC-conjugated rat anti-mouse CD4 (FITC-RM4-5, Cat. No. 553046) and 0.25 µg of APC-conjugated rat anti-mouse IL-10 antibody (APC-JES5-16E3, Cat. No. 554468) by using Pharmingen's staining protocol (left panel). To demonstrate specificity of staining, the binding of APC-JES5-16E3 was blocked by the preincubation of the conjugated antibody with a molar excess of recombinant mouse IL-10 (0.12 µg, Cat. No. 550070; middle panel), and by preincubation of the fixed/permeabilized cells with an excess of the unlabelled JES516E3 mAb (3.6 µg, Cat. No. 554464; right panel). The quadrant markers for the bivariate dot plots were set based on the autofluorescence control, and verified with the recombinant cytokine blocking (middle panel) and unlabeled antibody blocking (right panel) specificity controls. A suitable rat IgG2b isotype control for assessing levels of background staining on fixed/permeabilized mouse cells is APC-R35-38 (Cat. No. 556924); use at comparable concentrations to antibody of interest (e.g., ≤ 0.5 µg / 1 million cells). This APC-conjugated reagent can be used in any flow cytometer equipped with a a dye, HeNE or red diode laser. These include the dual laser FACStarPLUS™, FACS Vantage™ or FACSCalibur™.
本文来自投稿,不代表本人立场,如若转载,请注明出处:http://www.iamyjet.com/kangti/9610.html